Bulk XCE Tirzepatide for Research - CAS 2023788-19-2 with 99.7% Purity

XCE Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide demonstrates significant potential in metabolic research applications.

The XCE Tirzepatide compound appears as a white lyophilized powder with exceptional purity (99.7%). Its unique dual agonist properties make it particularly interesting for studies involving glucose metabolism and weight management mechanisms.

Research indicates that XCE Tirzepatide may influence multiple metabolic pathways simultaneously. The GIP receptor activation component appears to enhance pancreatic β-cell function, while the GLP-1 receptor activity contributes to appetite regulation and gastric emptying modulation.

For optimal preservation, XCE Tirzepatide should be stored in its lyophilized form at -20°C or below. The peptide maintains stability when protected from moisture, light, and repeated freeze-thaw cycles.

This product is supplied in research quantities with 10mg per vial. Each order includes comprehensive analytical documentation verifying the identity, purity, and composition of the material.

Important Note: XCE Tirzepatide is provided for laboratory research purposes only. This product is not intended for diagnostic, therapeutic, or human consumption applications.